HAMILTON, Ontario, June 18, 2019 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it has begun onboarding patients with two new physician practices in New Jersey and Maryland.

“We are very pleased to welcome two new clients in the Northeastern United States to the iUGO Care platform,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.  “In Maryland, our client is an Interventional Cardiology practice that is using the iUGO Care platform to manage high risk cardiac patients at home.  iUGO Care allows cardiologists to remotely monitor a wide range of relevant physiological parameters including blood pressure, blood glucose, pulse oxygenation, body mass and temperature, and even collect multi-day continuous electrocardiogram (ECG) data from a wearable ECG monitor.  In New Jersey the iUGO Care platform is being used by a Primary Care practice to provide proactive care and enable early interventions for patients with diabetes and hypertension.  Both clients provide care to Medicaid, Medicare and Medicare Advantage patients and are able to leverage the new billing codes CMS has introduced for remote patient monitoring and chronic care management.  Together these clients are expected to add over 1,000 billable patients to Reliq’s iUGO Care platform.”

Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare.  The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery.  iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

For further information please contact:

Investor Relations at ir@reliqhealth.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. 

Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.